Drug Information

Drug General Information
Drug ID
D0M2SR
Former ID
DIB002502
Drug Name
R-803
Synonyms
R-111706; R-940803
Drug Type
Small molecular drug
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Discontinued in Phase 1/2 [546948]
Company
Rigel Pharmaceuticals Inc
Structure
Download
2D MOL

3D MOL
Formula
C17H14O3
Canonical SMILES
CC(C(=O)O)c1cccc2c(coc12)c3ccccc3
InChI
1S/C17H14O3/c1-11(17(18)19)13-8-5-9-14-15(10-20-16(13)14)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)
InChIKey
ODZUWQAFWMLWCF-UHFFFAOYSA-N
PubChem Compound ID
37801
Target and Pathway
Target(s) Hepatitis C virus NS5B polymerase Target Info Modulator [1572591]
References
Ref 546948Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011431)
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.